Stifel analyst Nathan Jones raised the firm’s price target on Crane to $157 from $150 and keeps a Buy rating on the shares following “another strong quarter” with a Q1 beat and guidance raise. Management noted high confidence in the guidance with potential upside and stronger than expected markets in North America and China chemical, the analyst tells investors.